Potential therapies against SARS-CoV-2 virus evaluated in large-scale clinical trials

• Principais autores: Alin-Viorel Focsa (Autor), Magdalena Birsan (Autor), Maria Dragan (Autor), Diana Popovici (Autor), Catalina Daniela Stan (Autor)
• Formato: Livro
• Publicado em: Amaltea Medical Publishing House, 2022-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

COVID-19 is a viral disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The pathogenesis of SARS-CoV-2 infection in humans manifests as mild symptoms to severe respiratory failure. The development of vaccines against coronaviruses faces several inherent challenges in...